SUNNYVALE, CA, April 16 – MDS Analytical Technologies, a leader in innovative solutions for drug discovery and life sciences research, today announced that it will showcase two of its newer products for the European market – the SpectraMax® L microplate luminometer and MetaXpressPowerCore(TM) software – during its participation at the 15th Annual Society for Biomolecular Sciences (SBS) 2009 Conference and Exhibition, April 26-30, in Lille, France.

MDS Analytical Technologies will also demonstrate a range of its most popular and innovative imaging instruments and software products at this year’s event, including the FLIPRTETRA® system, CellKey(TM)384 system, the IonWorks® Quattro(TM) system, AquaMax® 4000 washer platform, ImageXpressMICRO(TM) system and IsoCyte(TM) laser scanning cytometer.

“We have a proud history of participation at SBS,” said Andy Boorn, President of MDS Analytical Technologies. “This conference and exhibition provides MDS Analytical Technologies with an excellent opportunity to showcase our latest technology, as well as gain valuable one-on-one interactions with our customers. Our ‘Screening Stimulus’-themed presence will highlight our latest innovations in imaging instruments and the software that runs on them.”

MDS Analytical Technologies will hold a pre-conference Drug Discovery Users Forum and will present several sessions at the conference. More specifically:

Pre-Conference Event:

Drug Discovery Users Forum

Saturday, April 25, 2009

This prominent event brings together influential and respected scientists to discuss assay and screening advances in drug discovery. For more information, visit the event page and register: https://www.moleculardevices.com/pages/dd_forum_2009.html

Tutorial:

New Development for MDS Analytical Technologies’ Complete Solution for

High Content Screening: Turning the Corner on Speed and Flexibility

Pierre Turpin, Ph.D., Product Marketing Manager

Monday, April 27, 2009

1:45 p.m. – 2:30 p.m. CEST

Faidherbe 2 at Lille Grand Palais

Main Session Presentation:

Novel Imaging and Analysis of Large Organisms for High-Throughput Assays

Evan Cromwell, Ph.D., Director of IsoCyte Operations

Tuesday, April 28, 2009

11:10a.m. – 11:35 a.m. CEST

Vaubaun Meeting Room

Tutorial:

Scale Your GPCR Assays with MDS Analytical Technologies’ New

SpectraMax® L Multi-Detector Luminometer and FLIPRTETRA System

Cathy Olsen, Ph.D., and Carole Crittenden, Application Scientists

Tuesday, April 28, 2009

8 a.m. – 8:45a.m. CEST

Charles de Gaulle 1 at Lille Grand Palais

Where to Find Us

Detailed presentations and product demonstrations are available at the MDS Analytical Technologies booth (booth 76). For conference information, please visit www.moleculardevices.com/SBS_2009

About MDS Analytical Technologies

MDS Analytical Technologies, a business unit of MDS Inc., is focused on the research, design, manufacture and marketing of state-of-the-art tools for mass-spectrometry, drug discovery and bioresearch. MDS Analytical Technologies’ products are designed to help accelerate the complex process of discovering and developing new drug compounds, and are sold to research scientists around the world. The mass-spectrometer product lines are also sold globally through joint ventures with two of the world’s leading analytical instrumentation and life-sciences companies, Life Technologies Corporation and PerkinElmer, Inc. Find out more at www.mdssciex.com or www.moleculardevices.com.

About MDS Inc.

MDS Inc. (TSX: MDS – News; NYSE: MDZ – News) is a global life-sciences company that provides market-leading products and services that our customers need for the development of drugs and diagnosis and treatment of disease. We are a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging, radiotherapeutics, and analytical instruments. MDS, Inc. has more than 5,000 highly skilled people in 29 countries. Find out more at www.mdsinc.com or by calling 1-888-MDS-7222, 24 hours a day.